Transverse Abdominal Plane Block for Caesarean
Efficacy of Transverse Abdominal Plane Block (TAP Block) With Bupivacaine and Dexamethasone for the Management of Post-cesarean Pain at the CHU Sourô Sanou (CHUSS) in Bobo-Dioulasso
1 other identifier
interventional
100
1 country
1
Brief Summary
Cesarean sectionis a commonly performed major surgical procedure that results in significant postoperative pain. The objective of this study was to evaluate the effectiveness in the management of post-cesarean pain at the CHU Souro Sanou of Bobo-Dioulasso
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 16, 2022
CompletedFirst Posted
Study publicly available on registry
October 20, 2022
CompletedStudy Start
First participant enrolled
October 20, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 20, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 20, 2023
CompletedSeptember 7, 2023
September 1, 2023
3 months
October 16, 2022
September 3, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proportion of mild pain on mobilization in the first 24 postoperative hours
The numerical pain score after moving from a lying position to a sitting position
Hours 24 postoperative
Secondary Outcomes (4)
Proportion of mild pain at rest in the first 24 postoperative hours
Hours 24 postoperative
Proportion of mild pain on mobilization in the first 48 postoperative hours
Hours 48 postoperative
Proportion of nausea-vomiting postoperative during the first 48 hours
Hours 48 postoperative
Proportion of maternal satisfaction during the first 48 hours postoperatively
Hours 48 postoperative
Study Arms (2)
group 1
NO INTERVENTIONwill receive at induction of spinal anesthesia 100 µg of morphine
group 2
EXPERIMENTALNo morphine in spinal anesthesia but will receive a bilateral TAP block with 20 ml of Bupivacaine 0.25% and dexamethasone 4 mg in the same syringe on each side
Interventions
Eligibility Criteria
You may qualify if:
- Adult parturients (≥ 18 years old) awaiting caesarean section under spinal anesthesia
- ASAI, ASAII
You may not qualify if:
- Lack of informed consent,
- Parturients with cognitive disorders,
- Parturients with notion of chronic pain,
- Allergy to local anesthetics,
- Morphine allergy
- Parturients not understanding pain assessment scores
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Souro Sanou
Bobo-Dioulasso, Houet, Burkina Faso
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical doctor
Study Record Dates
First Submitted
October 16, 2022
First Posted
October 20, 2022
Study Start
October 20, 2022
Primary Completion
January 20, 2023
Study Completion
February 20, 2023
Last Updated
September 7, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share